These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16337066)

  • 41. Analysis of the hemochromatosis mutations C282Y and H63D in infertile men.
    Peterlin B; Kunej T; Hruskovicová H; Ferk P; Gersak K; Zorn B
    Fertil Steril; 2006 Dec; 86(6):1796-8. PubMed ID: 17067586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of correcting transferrin saturation for body mass index in HFE C282Y homozygotes.
    Waalen J; Beutler E
    J Hepatol; 2006 Feb; 44(2):433-4; author reply 434-5. PubMed ID: 16364490
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 44. Hemochromatosis with HFE gene mutation in a Japanese patient.
    Sohda T; Okubo R; Kamimura S; Ohkawara T
    Am J Gastroenterol; 2001 Aug; 96(8):2487-8. PubMed ID: 11513196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hereditary hemochromatosis in Spain.
    Sánchez M; Bruguera M; Quintero E; Barrio Y; Mazzara R; Rodés J; Oliva R
    Genet Test; 2000; 4(2):171-6. PubMed ID: 10953957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of heterozygous hemochromatosis C282Y gene mutation with hand osteoarthritis.
    Ross JM; Kowalchuk RM; Shaulinsky J; Ross L; Ryan D; Phatak PD
    J Rheumatol; 2003 Jan; 30(1):121-5. PubMed ID: 12508400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Celtic origin of the C282Y mutation of hemochromatosis.
    Lucotte G
    Blood Cells Mol Dis; 1998 Dec; 24(4):433-8. PubMed ID: 9851897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of H63D, S65C and C282Y mutations of the HFE gene in 1120 voluntary blood donors from Antioquia region of northwest Colombia.
    Avila-Gomez IC; Aristizabal-Bernal B; Jimenez-Del-Rio M; Velez-Pardo C
    Blood Cells Mol Dis; 2008; 40(3):449-51. PubMed ID: 18289891
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetics of hemochromatosis.
    Cullen LM; Anderson GJ; Ramm GA; Jazwinska EC; Powell LW
    Annu Rev Med; 1999; 50():87-98. PubMed ID: 10073265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians.
    Coppin H; Bensaid M; Fruchon S; Borot N; Blanché H; Roth MP
    BMJ; 2003 Jul; 327(7407):132-3. PubMed ID: 12869454
    [No Abstract]   [Full Text] [Related]  

  • 52. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study.
    Stuhrmann M; Strassburg C; Schmidtke J
    Eur J Hum Genet; 2005 Jan; 13(1):69-78. PubMed ID: 15483651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterozygosity for the haemochromatosis mutation HFE C282Y is not a risk factor for angina.
    Feeney GP; Ashfield-Watt PA; Burr ML; Dunstan FD; McDowell IF; Worwood M
    Heart; 2004 Aug; 90(8):939-40. PubMed ID: 15253976
    [No Abstract]   [Full Text] [Related]  

  • 56. [Mutations in the HFE gene in patients with rheumatic diseases].
    Půtová I; Cimburová M; Jarosová K; Vencovský J; Horák J
    Cas Lek Cesk; 2005; 144(6):391-7; discussion 397-8. PubMed ID: 16047841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?
    Adams PC
    Mol Genet Metab; 2000; 71(1-2):81-6. PubMed ID: 11001800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neonatal screening for the hemochromatosis defect.
    Cullen LM; Summerville L; Glassick TV; Crawford DH; Powell LW; Jazwinska EC
    Blood; 1997 Nov; 90(10):4236-7. PubMed ID: 9354699
    [No Abstract]   [Full Text] [Related]  

  • 59. Analysis of HFE gene mutations (C282Y, H63D, and S65C) in the Ecuadorian population.
    Leone PE; Giménez P; Collantes JC; Paz-y-Miño C
    Ann Hematol; 2005 Feb; 84(2):103-5. PubMed ID: 15517265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-HFE-related hemochromatosis: the role of genetic factors.
    Castiella A; Zapata E; Otazua P; Zubiaurre L; Fernandez J
    Hepatology; 2010 Apr; 51(4):1473-4; author reply 1474. PubMed ID: 20373380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.